Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcriptional Activation | 4 | 2026 | 419 | 1.460 |
Why?
|
| Prostatic Neoplasms | 7 | 2022 | 1416 | 1.230 |
Why?
|
| Nuclear Receptor Coactivator 3 | 5 | 2021 | 257 | 1.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2026 | 26 | 0.970 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2025 | 2024 | 0.930 |
Why?
|
| Aconitate Hydratase | 2 | 2026 | 13 | 0.900 |
Why?
|
| Tumor Microenvironment | 4 | 2026 | 710 | 0.860 |
Why?
|
| Chromatin | 2 | 2026 | 499 | 0.840 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 7 | 0.830 |
Why?
|
| Photoacoustic Techniques | 1 | 2024 | 6 | 0.830 |
Why?
|
| Cell Nucleus | 1 | 2026 | 556 | 0.810 |
Why?
|
| Glutamine | 2 | 2022 | 200 | 0.770 |
Why?
|
| Bone Neoplasms | 3 | 2024 | 474 | 0.740 |
Why?
|
| Histones | 1 | 2026 | 541 | 0.740 |
Why?
|
| Cell Plasticity | 1 | 2022 | 42 | 0.720 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 2598 | 0.680 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 31 | 0.640 |
Why?
|
| Mitochondria | 2 | 2026 | 775 | 0.600 |
Why?
|
| Cell Line, Tumor | 14 | 2026 | 3733 | 0.580 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 22 | 0.550 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 147 | 0.530 |
Why?
|
| Glucose | 2 | 2018 | 851 | 0.480 |
Why?
|
| Biomarkers, Tumor | 3 | 2020 | 1581 | 0.470 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1362 | 0.410 |
Why?
|
| Mice | 15 | 2026 | 18199 | 0.400 |
Why?
|
| Neoplasms | 2 | 2022 | 2994 | 0.400 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2013 | 64 | 0.380 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2022 | 359 | 0.360 |
Why?
|
| Energy Metabolism | 2 | 2015 | 803 | 0.350 |
Why?
|
| Animals | 18 | 2026 | 33731 | 0.350 |
Why?
|
| Reproduction | 1 | 2013 | 210 | 0.350 |
Why?
|
| Annexin A2 | 3 | 2019 | 4 | 0.350 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2026 | 195 | 0.320 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 713 | 0.320 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 2319 | 0.310 |
Why?
|
| Glycolysis | 2 | 2022 | 173 | 0.300 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 1545 | 0.300 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 280 | 0.290 |
Why?
|
| Receptors, Androgen | 2 | 2023 | 408 | 0.290 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2023 | 105 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 1009 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2025 | 814 | 0.280 |
Why?
|
| Receptors, Estrogen | 2 | 2024 | 724 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 585 | 0.270 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2460 | 0.270 |
Why?
|
| Phosphorylation | 5 | 2018 | 1570 | 0.250 |
Why?
|
| Pancreatic Neoplasms | 2 | 2026 | 739 | 0.250 |
Why?
|
| Mice, Nude | 2 | 2020 | 699 | 0.240 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 679 | 0.240 |
Why?
|
| Alprazolam | 1 | 2026 | 7 | 0.240 |
Why?
|
| Acetyl Coenzyme A | 1 | 2026 | 18 | 0.240 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2026 | 47 | 0.240 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2026 | 24 | 0.240 |
Why?
|
| Acetylation | 1 | 2026 | 191 | 0.230 |
Why?
|
| Histone Acetyltransferases | 1 | 2026 | 226 | 0.230 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2026 | 79 | 0.230 |
Why?
|
| Cell Movement | 4 | 2018 | 875 | 0.220 |
Why?
|
| IMP Dehydrogenase | 1 | 2025 | 26 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2014 | 2403 | 0.210 |
Why?
|
| Humans | 24 | 2026 | 130515 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2025 | 288 | 0.200 |
Why?
|
| TNF Receptor-Associated Factor 4 | 2 | 2023 | 13 | 0.190 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 43 | 0.180 |
Why?
|
| Circadian Rhythm | 2 | 2015 | 319 | 0.180 |
Why?
|
| Mice, SCID | 3 | 2018 | 585 | 0.160 |
Why?
|
| Cytokines | 1 | 2026 | 1332 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 631 | 0.160 |
Why?
|
| Genes, myc | 1 | 2019 | 96 | 0.150 |
Why?
|
| Castration | 1 | 2019 | 27 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2024 | 942 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 974 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 236 | 0.140 |
Why?
|
| Metabolomics | 1 | 2022 | 500 | 0.140 |
Why?
|
| Phosphoserine | 1 | 2018 | 38 | 0.140 |
Why?
|
| Transketolase | 1 | 2018 | 17 | 0.140 |
Why?
|
| Receptor, trkA | 1 | 2018 | 18 | 0.140 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 358 | 0.140 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.140 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 34 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 251 | 0.130 |
Why?
|
| Purines | 1 | 2018 | 117 | 0.130 |
Why?
|
| Prognosis | 4 | 2025 | 4866 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 318 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2019 | 2544 | 0.120 |
Why?
|
| Hexosamines | 1 | 2016 | 16 | 0.120 |
Why?
|
| RNA Interference | 1 | 2018 | 491 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Male | 12 | 2023 | 64587 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2015 | 21 | 0.120 |
Why?
|
| Protein Binding | 3 | 2015 | 1651 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 51 | 0.110 |
Why?
|
| Female | 9 | 2025 | 70546 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2015 | 61 | 0.110 |
Why?
|
| Gene Expression | 2 | 2015 | 1482 | 0.100 |
Why?
|
| Apoptosis | 1 | 2020 | 1821 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 436 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2015 | 688 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2015 | 105 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2015 | 450 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 195 | 0.100 |
Why?
|
| DNA | 2 | 2016 | 1397 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1265 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 825 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2013 | 732 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 711 | 0.080 |
Why?
|
| Metabolome | 1 | 2014 | 325 | 0.080 |
Why?
|
| Liver | 2 | 2015 | 1788 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2023 | 174 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2010 | 34 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2019 | 4663 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 888 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2019 | 826 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 378 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2019 | 440 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 2 | 2015 | 45 | 0.050 |
Why?
|
| Disease Progression | 3 | 2019 | 2192 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 480 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 105 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 662 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2024 | 307 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2022 | 175 | 0.040 |
Why?
|
| Androgens | 1 | 2023 | 246 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2021 | 3819 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2019 | 434 | 0.030 |
Why?
|
| Heterografts | 1 | 2018 | 189 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 299 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2019 | 927 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 903 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 570 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 82 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1480 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2897 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2015 | 79 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1283 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 189 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 135 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 335 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 201 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 196 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 366 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 273 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 355 | 0.030 |
Why?
|
| Cadherins | 1 | 2014 | 182 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 593 | 0.020 |
Why?
|
| Binding Sites | 1 | 2016 | 1133 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 394 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 253 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 1614 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1069 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2552 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 994 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 60 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 144 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5048 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 223 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 28420 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 747 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 303 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 645 | 0.020 |
Why?
|
| Transcriptome | 1 | 2014 | 1097 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1814 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17650 | 0.010 |
Why?
|